| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 7,186 | -6,703 |
| Depreciation and amortization | 111,275 | 71,476 |
| Noncash operating lease expense | 44,605 | 29,356 |
| Equity in earnings of joint ventures, net of dividends | 4,590 | 1,267 |
| Amortization of deferred financing costs and loan discount | 2,242 | 1,471 |
| Loss on sale and disposal of equipment | -3,168 | -2,126 |
| Loss on extinguishment of debt | 0 | 0 |
| Lease abandonment charges | -8,330 | -5,511 |
| Amortization of cash flow hedge | 2,273 | 2,712 |
| Non-cash change in fair value of interest rate swap | -6,433 | -4,062 |
| Stock-based compensation | 46,276 | 37,235 |
| Loss on impairment | 0 | - |
| Change in fair value of contingent consideration | 0 | 0 |
| Accounts receivable | 20,476 | 14,159 |
| Other current assets | -2,093 | -22,381 |
| Other assets | 2,764 | 2,544 |
| Deferred taxes | -2 | 3,511 |
| Operating leases | -48,760 | -34,726 |
| Deferred revenue | 3,934 | 145 |
| Accounts payable, accrued expenses and other | 53,429 | 48,264 |
| Net cash provided by operating activities | 214,656 | 161,829 |
| Purchase of imaging facilities and other acquisitions, net of cash acquired | 66,464 | 31,985 |
| Purchase of property and equipment and other | 162,221 | 101,776 |
| Proceeds from sale of equipment | 75 | 40 |
| Equity contributions in existing and purchase of interest in joint ventures | 4,147 | 20,480 |
| Collection of notes receivable | 2,832 | - |
| Net cash used in investing activities | -229,925 | -154,201 |
| Principal payments on notes and leases payable | 5,229 | 3,461 |
| Payments on term loan debt | 15,504 | 10,252 |
| Proceeds from issuance of new debt, net of issuing costs | 99,001 | 99,001 |
| Purchase of noncontrolling interests by third party | 2,389 | 2,389 |
| Payments on contingent consideration and holdbacks | 0 | 0 |
| Distributions paid to noncontrolling interests | 3,313 | 3,313 |
| Proceeds from sale of economic interests in majority owned subsidiary, net of taxes | 0 | 0 |
| Proceeds from issuance of common stock | 0 | 0 |
| Proceeds from issuance of common stock upon exercise of options | 2,258 | 554 |
| Net cash provided by financing activities | 79,602 | 84,918 |
| Effect of exchange rate changes on cash | 363 | 586 |
| Net increase in cash and cash equivalents | 64,696 | 93,132 |
| Cash and cash equivalents at beginning of period | 740,020 | - |
| Cash and cash equivalents at end of period | 804,716 | - |
RadNet, Inc. (RDNT)
RadNet, Inc. (RDNT)